EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 22-Jun-2026 05:15 ET (22-Jun-2026 09:15 GMT/UTC)

19-May-2026

Where you have rectal cancer surgery may affect whether the cancer comes back

American College of Surgeons
Peer-Reviewed Publication

Having surgery for rectal cancer at a hospital accredited by the National Accreditation Program for Rectal Cancer was associated with a significant reduction in cancer remaining at the edges of the tumor site, compared to having the same surgery at a non-accredited hospital.

Journal: Journal of the American College of Surgeons

19-May-2026

Nicotine e-cigarettes reduce harmful chemical exposure, help smokers quit

Penn State
Peer-Reviewed Publication

In the first U.S. randomized placebo-controlled trial of its kind, researchers from Penn State College of Medicine found that smokers who switched from traditional cigarettes to pod-based salt-nicotine e-cigarettes were three times more likely to quit smoking within six weeks and were exposed to lower levels of harmful tobacco-related toxicants.

Journal: JAMA Network Open
Funder: U.S. Food and Drug Administration

19-May-2026

Nervous system helps lung cancer evade the immune system

The Francis Crick Institute
Peer-Reviewed Publication

Researchers at the Francis Crick Institute have revealed that sensory nerve signals interfere with the immune system’s response to lung cancer. This previously unrecognised neuroimmune connection could be targeted to improve responses to immunotherapy.

Journal: Cell

19-May-2026

‘Jumping gene’ helps explain elevated pancreatic cancer risk in French-Canadians

McGill University
Peer-Reviewed Publication

Researchers at McGill University have discovered a centuries-old genetic mutation that helps to explain why some French‑Canadians in Quebec are at an elevated risk of pancreatic cancer. Until quite recently, standard genetic tests have not been able to identify this “jumping gene” cause.

The findings, published in the Journal of Medical Genetics, suggest better-targeted genetic testing could help identify people at higher cancer risk who were previously missed.

Journal: Journal of Medical Genetics

19-May-2026

USC comparison study of leading targeted therapies for ALK+ lung cancer could lead to better treatment decisions

Keck School of Medicine of USC
Peer-Reviewed Publication

A team of researchers from USC have conducted a head-to-head comparison of five leading treatments for anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer. It is the first study to analyze two new drugs, lorlatinib and brigatinib, outside of clinical trials. The findings, just published in the journal Lung Cancer, could help patients and physicians make more informed decisions about treatment.

Journal: Lung Cancer

19-May-2026

Hierarchical tissue-specific modeling of pathology images predicts response in HER2+ breast cancer

Beijing Institute of Technology Press Co., Ltd
Peer-Reviewed Publication

A research paper by scientists at Hangzhou Dianzi University presented a HER2+ breast cancer response prediction model based on hierarchical tissue specific modeling of pathological images.

The research paper, published on Apr 22, 2026 in the journal Cyborg and Bionic Systems.

Journal: Cyborg and Bionic Systems

19-May-2026

NIR-propelled biomimetic nanomotors for photothermal/chemodynamic/NO synergistic tumor therapy

Beijing Institute of Technology Press Co., Ltd
Peer-Reviewed Publication

A research paper by scientists from Southern University of Science and Technology developed a near-infrared (NIR) light-activated biomimetic nanomotor for targeted nitric oxide (NO) delivery and synergistic cancer therapy.

The new research paper, published on Apr. 24 in the journal Cyborg and Bionic Systems, developed a new light‑activated nanomotor platform combines photothermal therapy, chemodynamic therapy, and nitric oxide (NO) gas therapy in one tiny, tumor‑hunting vehicle.

Journal: Cyborg and Bionic Systems

19-May-2026

New Houston Methodist study shows growing breast cancer risk for younger women, improved outcomes for older women

Houston Methodist
Peer-Reviewed Publication

A national study analyzing U.S. breast cancer data spanning nearly 50 years has uncovered a major shift in outcomes and risk of developing the disease, highlighting urgent gaps in prevention and treatment for specific groups of women.

Journal: npj Breast Cancer

19-May-2026

Brain Network Disorders article reviews the adoption of AI in brain cancer segmentation

Brain Network Disorders Editorial Office
Peer-Reviewed Publication

As AI is being widely tested in medicine, scientists at the University of Auckland, Auckland City Hospital, and Matai Medical Research Institute in New Zealand have analyzed the current landscape of AI models for meningioma (a cancer of the brain’s soft cover) segmentation from MRI scans, and its path ahead. Their key finding is that advanced model architecture has considerably contributed to tumor detection sensitivity, rather than data characteristics, imaging modalities, or preprocessing.

Journal: Brain Network Disorders

19-May-2026

TAILORx and RxPONDER trials shift to a discovery platform for analyzing breast cancer recurrence using advanced tumor profiling and AI

ECOG-ACRIN Cancer Research Group
Business Announcement

One of the world's largest breast cancer tissue banks is being used to study how tumors evolve and identify markers that indicate the risk of cancer recurrence. The ECOG-ACRIN and SWOG research groups are collaborating with Caris Life Sciences to use advanced tumor profiling and artificial intelligence to analyze these samples and related information, aiming to better understand what drives an incurable late recurrence of breast cancer in other parts of the body years after the initial diagnosis.

Funder: U.S. Department of Defense